Inter-hemispheric asymmetry of nigrostriatal dopaminergic lesion: a possible compensatory mechanism in Parkinson's disease

被引:51
|
作者
Blesa, Javier [1 ,2 ]
Juri, Carlos [1 ,3 ]
Garcia-Cabezas, Miguel A. [4 ,5 ]
Adanez, Rebeca [1 ,2 ]
Sanchez-Gonzalez, Miguel A. [4 ,5 ]
Cavada, Carmen [4 ,5 ]
Obeso, Jose A. [1 ,2 ]
机构
[1] Clin Univ Navarra, Ctr Invest Med Aplicada, Dept Neurol & Neurociugia, Lab Trastornos Movimiento,Neurociencias, Pamplona, Spain
[2] Inst Carlos III, Minist Ciencia & Innovat, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain
[3] Pontificia Univ Catolica Chile, Dept Neurol, Santiago, Chile
[4] Univ Autonoma Madrid, Fac Med, Dept Anat Histol & Neurociencia, Madrid, Spain
[5] Inst Invest Sanitaria IdiPAZ, Madrid, Spain
来源
FRONTIERS IN SYSTEMS NEUROSCIENCE | 2011年 / 5卷
关键词
MPTP; Parkinson's disease; PET; dopaminergic; F-18-DOPA; compensatory mechanisms;
D O I
10.3389/fnsys.2011.00092
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The onset of Parkinson's disease (PD) is characterized by focal motor features in one body part, which are usually correlated with greater dopaminergic depletion in the contralateral posterior putamen. The role of dopamine (DA) hemispheric differences in the onset and progression of motor symptoms of PD, however, remains undefined. Previous studies have demonstrated that unilateral manipulations of one nigrostriatal system affect contralateral DA turnover, indicating a functional and compensatory inter-dependence of the two nigrostriatal systems. In preliminary data obtained by our group from asymmetric PD patients, a higher asymmetry index as measured by 6-[F-18]fluoro-L-dopa (F-18-DOPA) positron emission tomography (PET) was associated with a higher threshold (i.e., greater dopaminergic loss) for the onset of motor symptoms in the less-affected side. To further elucidate the underlying basis for this, we carried out a complementary study in monkeys using PET to assess and correlate the degree of dopaminergic striatal depletion with motor activity. Control and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-intoxicated monkeys with symmetrical lesions were characterized behaviorally and with F-18-DOPA PET. In parallel, an acute lesion was inflicted in the nigrostriatal projection unilaterally in one monkey, generating a 30% dopaminergic depletion in the ipsilateral striatum, which was not associated with any noticeable parkinsonian feature or deficit. The monkey remained asymptomatic for several months. Subsequently, this monkey received systemic MPTP, following which motor behavior and PET were repeatedly evaluated during progression of parkinsonian signs. The brains of all monkeys were processed using immunohistochemical methods. Our results suggest that the onset of motor signs is related to and influenced by the dopaminergic status of the less-affected, contralateral striatum. Although this work is still preliminary, the study agrees with our general hypothesis of hemispheric inter-dependence in the compensation of striatal DA deficit in PD
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?
    Vingerhoets, FJG
    Schulzer, M
    Caine, DB
    Snow, BJ
    ANNALS OF NEUROLOGY, 1997, 41 (01) : 58 - 64
  • [32] Oestrogen and nigrostriatal dopaminergic neurodegeneration: Animal models and clinical reports of Parkinson's disease
    Liu, Bin
    Dluzen, Dean E.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2007, 34 (07) : 555 - 565
  • [33] In vivo modulation of dopaminergic nigrostriatal pathways by cytisine derivatives:: Implications for Parkinson's Disease
    Abin-Carriquiry, J. Andres
    Costa, Gustavo
    Urbanavicius, Jessika
    Cassels, Bruce K.
    Rebolledo-Fuentes, Marco
    Wonnacott, Susan
    Dajas, Federico
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 589 (1-3) : 80 - 84
  • [34] Colour vision abnormalities do not correlate with dopaminergic nigrostriatal degeneration in Parkinson's disease
    Muller, T
    Kuhn, W
    Buttner, T
    Eising, E
    Coenen, H
    Haas, M
    Przuntek, H
    JOURNAL OF NEUROLOGY, 1998, 245 (10) : 659 - 664
  • [35] Effect of Different Doses of Estrogen on the Nigrostriatal Dopaminergic System in Two 6-Hydroxydopamine-Induced Lesion Models of Parkinson's Disease
    Cordellini, Marcela Ferreira
    Piazzetta, Giovana
    Pinto, Karin Cristine
    Delattre, Ana Marcia
    Matheussi, Francesca
    Carolino, Ruither O. G.
    Szawka, Raphael Escorsim
    Anselmo-Franci, Janete A.
    Ferraz, Anete Curte
    NEUROCHEMICAL RESEARCH, 2011, 36 (06) : 955 - 961
  • [36] Effect of Different Doses of Estrogen on the Nigrostriatal Dopaminergic System in Two 6-Hydroxydopamine-Induced Lesion Models of Parkinson’s Disease
    Marcela Ferreira Cordellini
    Giovana Piazzetta
    Karin Cristine Pinto
    Ana Márcia Delattre
    Francesca Matheussi
    Ruither O. G. Carolino
    Raphael Escorsim Szawka
    Janete A. Anselmo-Franci
    Anete Curte Ferraz
    Neurochemical Research, 2011, 36 : 955 - 961
  • [37] Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson's disease
    Drui, G.
    Carnicella, S.
    Carcenac, C.
    Favier, M.
    Bertrand, A.
    Boulet, S.
    Savasta, M.
    MOLECULAR PSYCHIATRY, 2014, 19 (03) : 358 - 367
  • [38] Colour vision abnormalities do not correlate with dopaminergic nigrostriatal degeneration in Parkinson’s disease
    T. Müller
    Wilfried Kuhn
    Thomas Büttner
    Ernst Eising
    H. Coenen
    Martin Haas
    Horst Przuntek
    Journal of Neurology, 1998, 245 : 659 - 664
  • [39] Mechanism of action of dopaminergic agents in Parkinson's disease
    Koller, WC
    Rueda, MC
    NEUROLOGY, 1998, 50 (06) : S11 - S14
  • [40] Zonisamide reduces nigrostriatal dopaminergic neurodegeneration in a mouse genetic model of Parkinson's disease
    Sano, Hiromi
    Murata, Miho
    Nambu, Atsushi
    JOURNAL OF NEUROCHEMISTRY, 2015, 134 (02) : 371 - 381